Challenges in the Diagnosis of (Micro)Invasive Carcinoma

72
Challenges in the Diagnosis of (Micro)Invasive Carcinoma Adriana Corben, MD Director Breast Pathology Fellowship

Transcript of Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Page 1: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Challenges in the Diagnosis of

(Micro)Invasive Carcinoma

Adriana Corben, MD

Director Breast Pathology Fellowship

Page 2: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Overview

• Microinvasion

– Helpful clues

– Immunostains and pitfalls in interpretation

– Clinical significance

• Invasive ca that mimics benign

• Invasive ca that mimics in situ

• Benign that mimics invasive ca

Page 3: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Microinvasion

Page 4: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

2010 AJCC Staging Manual

• T1mi

• “Extension of cancer cells beyond the basement

membrane…as an invasive ca with no focus

measuring >1 mm”

• Not connected with CIS

• No need to subtype

• ‼ If multiple foci, should not be added together

• An attempt to quantify them should be included

• Prognosis is generally quite favorable

• Clinical impact of multifocality is not well understood

Page 5: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Always r/o microinvasion if…

• High grade or comedo-type DCIS

– Other DCIS types can also have it

• Comedo-type or pleomorphic LCIS

• Extensive CIS

• Periductal lymphoid infiltrates

• Mucocele-like lesions

Page 6: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Useful lower-power field tools

• Irregularity of the contour of the nests/glands

• Retraction around the invasive nests

• Tumor nests/glands without a lobulocentric

organization

• Chronic inflammation

• Reactive stroma

• Increased stromal cellularity

• DCIS: blurred edges of the duct wall due to

tangential sectioning

Page 7: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Useful higher-power field tools

• Irregularity of the contour of the nests/glands

• No basement membrane (BM): tumor cells

directly abut the stroma/adipose tissue

• No myoepithelial cells on H&E

• Retraction around the invasive nests

Page 8: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

•DCIS with

smooth contours

(below)

•Microinvasive

carcinoma with

irregular contours

(above)

Page 9: Challenges in the Diagnosis of (Micro)Invasive Carcinoma
Page 10: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

IDC: absent lobular arrangement around benign

Page 11: Challenges in the Diagnosis of (Micro)Invasive Carcinoma
Page 12: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Invasion

Page 13: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

•Stromal (periductal)

chronic inflammation

needs closer

evaluation

•‼ Useful: at final

margins → levels!

Page 14: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Invasive lobular carcinoma with lymphocytes

HMW-CK

Page 15: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Reactive stroma and increased stromal cellularity

Page 16: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Microinvasive lobular simulates lymphocytes

Page 17: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

DCIS: tangential

sectioning of the

duct wall will

create a blurred

edge

Page 18: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Helpful studies

• Definitive diagnosis is not always possible

on H&E

• ‼ Most useful adjunctive studies:

– IHC: at least 2 myoepithelial markers

Page 19: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Assessing invasion by IHC

• Invasive carcinoma:

– Lack of both basement membrane and

myoepithelial cells

• Benign and in situ lesions:

– Presence of both basement membrane and

myoepithelial cells

Page 20: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Myoepithelial cell markers

Marker Sensitivity Specificity

S-100 Good Unacceptable

Actin Good Poor

SMMHC Good Excellent

Calponin Excellent Very good

HMW-CK Very good Poor

Adapted from Yaziji, et al. Adv Anat Pathol 2000, 7:100-109

Page 21: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Calponin

Page 22: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Calponin: easily overlooked microinvasive carcinoma

Page 23: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

An H&E section

paired with 2

myoepithelial cell

markers is critical

Page 24: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

MOST COMMONLY

USED

USED RARELY USED

CALPONIN CK5/6 S100

SMMHC CD10

SMA 34B12

p63

Page 25: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

p63

•p53 family

•Nuclei only

•High sensitivity

•High specificity

•No myofibroblast

staining

•Positive in some

DCIS and IDC

(metaplastic)

Page 26: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Tubular adenosis

Calponin

Page 27: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

SMMHC

Tubular adenosis

Page 28: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Invasive tubular ca with SMA positive myofibroblasts

Page 29: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Myofibroblast cross-reactivity of

myoepithelial cell markers

SMA +++

Calponin ++

SMMHC +

p63 -

Page 30: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

A HMW-CK paired with 2 myoepithelial cell markers is critical

Page 31: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Lobular carcinoma

cells invade the

interlobular

collagenous stroma

Page 32: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Multinucleated stromal giant cells

Cytokeratin

Page 33: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Clinical significance of

microinvasion

• Studies in the past:

– small numbers

– varying definitions

– varying degrees of tissue sampling

• No clear differences from pure DCIS

• Clinical significance is unclear

Page 34: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Single cells in the stroma:

what do they mean? De Mascarel, Cancer 2002; 94:2134

Page 35: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Axillary LN involvement

and 10 yrs outcome

De Mascarel, Cancer, 2002

#pts %node+

DCIS 722 1.4%

DCIS +

single cells

in stroma

72 0

DDFS OS

DCIS 98% 96.5%

DCIS +

single cells

in stroma

97% 96.3%

Page 36: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Single cells in the stroma:

what do they mean?

• No evidence that:

– Is associated with

axillary LN +

– Has adverse clinical

outcome

• In practice, we

consider them

microinvasion

• By using AJCC

definition pts will likely

have:

– Very low rate of ALNM

– Cure rate approaching

100% with good local

treatment

• Goal: identify this

subset of pts

Page 37: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Invasive Carcinoma

that Mimics Benign

Page 38: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Useful clues

• Glandular disarray

• Irregular tubules/glands of variable

size/shape/orientation

• Infiltration around benign

• Open glandular lumina

• Lack of BM and myoepithelium

• Stromal hypercellularity

• Stromal desmoplasia

Page 39: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

IDC mimicking benign adenosis

Page 40: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

SMMHC

Page 41: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Invasive ductal carcinoma surrounding DCIS

Page 42: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Invasive carcinoma within sclerosing adenosis

Page 43: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

IDC mimics benign breast, but no BM and myoepithelium

Page 44: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Suspect ILC: Stromal hypercellularity and desmoplasia

Page 45: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Invasive carcinoma

that mimics in situ

Page 46: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Problematic patterns

• Nested invasion

• Blunt invasion

• Occlusive LVI

Page 47: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Clues for nested invasion

• Too confluent and/or haphazard

distribution

• Large nests adjacent to completely normal

lobules

• Irregularities in the contour of the nests

• Reactive stroma (if present)

• The following two pictures show how IDC

can mimic DCIS

Page 48: Challenges in the Diagnosis of (Micro)Invasive Carcinoma
Page 49: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Clues for blunt invasion

• Common in solid papillary carcinoma and

papillary carcinoma

• Too large nests

• Discontinuity along the periphery of the

nests

• Fat, collagen, large vessels or benign

glands entrapped

Page 50: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Large size of

the nests

raises

concern of

blunt

invasion

Page 51: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Case initially misdiagnosed as DCIS

p63 SMA

Page 52: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

IDC vs DCIS

Calponin

Page 53: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Invasive Papillary Carcinoma

Page 54: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

p63

Page 55: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Clues for occlusive LVI

• Buckshot distribution

• In arteries and veins

• Carcinoma associated with vascular

bundle

• D2-40 + and p63 –

• ‼ Issue: foci near margins

• The next 2 pictures show occlusive LVI

mimicking DCIS

Page 56: Challenges in the Diagnosis of (Micro)Invasive Carcinoma
Page 57: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

D2-40

• Ab to human

podoplanin

• Used to identify

lymphatic vessels

• Less myofibroblast

staining

• ‼ DCIS or LCIS with

retraction could be

misinterpreted as LVI

(and viceversa)

Page 58: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Benign lesions that mimic

invasive carcinoma

Page 59: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Sclerosing and pseudoinvasive

lesions

• Radial scar/complex sclerosing lesion

• Sclerosing adenosis

• Involvement of benign lesions by CIS

• Microglandular adenosis (MGA)

• Multinucleated stromal giant cells

• Mucocele-like lesions

• Sclerosing papillary lesions

Page 60: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Radial Scar Nidus

Page 61: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Tubular Carcinoma

Page 62: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Radial Scar Nidus

DCIS UDH

Page 63: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Sclerosing adenosis

Page 64: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

ALH in sclerosing

adenosis

Invasive lobular

carcinoma

Page 65: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

DCIS involving a sclerosing lesion

Calponin

Page 66: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

MGA vs Tubular ca:

• Fibrotic stroma

• Uniform, round

tubules

• No snouts

• Eosinophilic colloid-

like secretion

• Prominent BM

• ER negative

• S100 positive

• ‼ Myoep negative

Page 67: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

MGA reported associated with

ca in up to 25% of cases

• Rosenblum Am J Surg Pathol

1986;10:237

• James Am J Clin Pathol

1993;100:507

• Acs Am J Surg Pathol

2003;27:1052

• Resetkova Arch Pathol Lab

Med 2003;127:77

• Salarieh, Sneige Arch Pathol

Lab Med 2007;131:1397

AMGA

Page 68: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

MGA and Carcinoma

•Similar immunoprofile

• ER -

• Myoeps -

• S100 +

•Overlapping genetic

alterations

•Suggested transition as a

non-obligate precursor

Shin S, et al. Am J Surg Pathol

2009;33;496

Page 69: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Recurrent issues with MGA

• Core biopsy

– Difficult to recognize

– Recommend excision

• Surgical specimen

– MGA at margin → complete excision

Page 70: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Artifactual displacement

Page 71: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Artifactual displacement

• Epithelium confined to

biopsy site

• Benign cytology with

round and “shrunken”

glands

• Benign primary lesion

• Myoepithelial cells may

or may not be retained

– More useful, if positive

– p63 more specific

Page 72: Challenges in the Diagnosis of (Micro)Invasive Carcinoma

Summary

• Microinvasion

– Helpful clues

– Immunostains and pitfalls in interpretation

– Clinical significance

• Invasive ca that mimics benign

• Invasive ca that mimics in situ

• Benign that mimics invasive ca